Term sheets compound quietly
Term sheets are short documents that compound over years. The 4-page sheet you sign at seed defines economic reality at every subsequent round, every employee's ESOP outcome, and the exit math when you eventually have one. Founders routinely focus on valuation and gloss over six other terms that matter as much or more.
This is the field guide to the terms that quietly cost founders millions, with specific dollar examples and named sources from startup law firm NEXT Law. We use this internally to prep founders during Phase 1 mock sessions.
Liquidation preference flavor
Liquidation preference defines who gets paid first in a sale or liquidation. The baseline is 1x non-participating preferred: investors get back either their investment amount or their as-converted ownership percentage, whichever is higher. Not both, according to NEXT Law's term sheet guide.
Here's what the variations cost you:
1x non-participating is the baseline for healthy seed and Series A rounds. Investor picks the larger of (preference) or (pro-rata). This is what you want.
1x participating preferred means the investor takes their preference and their pro-rata share of the remainder. Effectively double-dipping on the exit. Only acceptable in distressed or down-round contexts, and even then it's a bitter pill.
2x or 3x preference means the investor gets 2x or 3x their money back before any common stock sees a dollar. At a $20M acquisition with $4M of 3x preferred outstanding, $12M goes to preferred holders before founders see anything. This is a severe problem.
Walk through the math on a real exit. You raised $4M at $16M post-money on 1x non-participating preferred. Company sells for $20M. Investors get $5M (their pro-rata of 25%); founders and ESOP split $15M.
Same company, same exit, but with 1x participating: investors get $4M preference plus 25% of the remaining $16M, which is $8M total. Founders and ESOP split $12M. $3M moved from founder pocket to investor pocket on terms that look identical on the cap table.
Anti-dilution provisions
Anti-dilution protects investors if you raise a future round at a lower price. There are three flavors, and two of them are poison.
Broad-based weighted average is the market norm and what you should accept. It adjusts the conversion ratio based on the magnitude of the down round and the proportion of new stock issued. The math hurts but proportionally.
Narrow-based weighted average excludes ESOP and other categories from the denominator, making the adjustment more aggressive. Slightly worse for founders but not catastrophic.
Full ratchet resets the investor's conversion price to the lowest price ever issued. A single small down round can massively dilute founders, per NEXT Law's guidance. We've seen this destroy cap tables.
Here's the full ratchet math. Investor put in $5M at $20M post (25% ownership). Two years later, you raise a $2M bridge at a $10M post-money cap. Under broad-based, founders take 5-10% additional dilution. Under full ratchet, the investor's conversion price resets and they go from 25% to potentially 40-50% ownership in a single move. Many full-ratchet down rounds end with founders owning less than 10% of their own company.
Hold the line on broad-based weighted average. Full ratchet at seed is a hard pass.
Board composition
A 3-person board is typical at seed. The composition matters more than the count.
2 founders, 1 investor is founder-friendly and common at small seed rounds. You control the board.
1 founder, 1 investor, 1 independent (founder-selected) is balanced and the norm for most clean Series A rounds. The independent is someone you picked, so you effectively have 2 votes.
1 founder, 1 investor, 1 independent (mutually agreed) is slightly less founder-friendly because the "mutually agreed" person becomes a swing vote. You don't control them.
1 founder, 2 investors means an investor-controlled board. This is fine at later stages but a problem at seed.
Pay attention to the protective provisions list alongside the board count. What requires board approval matters as much as who's on the board. You (the CEO) should be able to hire and fire executives, set strategy, and make budget decisions without board sign-off.
Protective provisions and veto rights
Protective provisions are the list of decisions that require investor consent. Some are fine; expansive ones are operational paralysis.
Acceptable provisions:
- Issuing new equity senior to or pari passu with existing preferred
- Selling the company
- Changing the certificate of incorporation in ways that materially affect preferred
- Liquidating or dissolving
Watch for these:
- Investor consent required for hiring or firing the CEO
- Investor consent required for annual budgets
- Investor consent required for material business plan changes
- Investor consent required for hires above a certain salary
- Investor consent required for any debt above a small threshold
NEXT Law flags this explicitly: "Founders should be wary of any provisions granting an investor excessive control and veto rights." Each veto right is small in isolation. The cumulative effect of 8-10 of them is that you can't move without permission.
No-shop and exclusivity windows
A no-shop clause prevents you from talking to other investors for a defined window after signing the term sheet. Reasonable is 30-45 days. Anything past 60 days is a problem.
NEXT Law calls out "overly restrictive no-shop clauses that exceed 90 days" as a red flag. If the deal falls apart 75 days in, the rest of your investor list has gone cold and you have to start the round over from scratch.
Negotiate the no-shop down to 30 days where possible. If the lead requires more, attach a fall-out clause: if they don't fund within X days, the no-shop terminates.
Founder vesting
Most seed term sheets impose 4-year vesting with a 1-year cliff on founder shares. Accept this. Investors will not back un-vested founders.
Watch for these variations:
Vesting that starts at the round close instead of at company formation is a problem. If you've been working on the company for 18 months, you should get credit for that time as "already vested."
Single-trigger acceleration on change of control is the norm. Hold for it.
No double-trigger acceleration on termination after acquisition means a founder can be fired after acquisition with no acceleration. Negotiate at least double-trigger.
Reverse vesting that extends to 5 or 6 years is excessive. 4 years is the market.
ESOP pool and the dilution hidden inside
The ESOP pool is the percentage of company equity reserved for employees. Most institutional investors want 8-15% pool at the seed round, expanded to 12-18% at Series A.
The hidden cost: the term sheet usually specifies that the pool is created or expanded pre-money, which means founders absorb the full dilution. If the pool is created post-money, both founders and investors share the dilution proportionally.
Walk through the math. You're raising $4M at $16M post on a 12% pool.
Pre-money pool (typical, founder-unfriendly): The pool comes out of the founder's pre-money equity. Founders take 100% of the dilution from the pool expansion. Effective dilution: 25% (the round) + 12% (the pool) = 37%.
Post-money pool (founder-friendly): Both sides share. Founders take 75% of the pool dilution; investors take 25%. Effective founder dilution: 25% + 9% = 34%.
Three percentage points moved between the two structures. On a $20M post that's $600K of effective value transferred. At later rounds the dollars get larger.
Other terms worth checking
Drag-along rights are fine. Just ensure the threshold to drag is reasonable (50-65% of preferred plus a majority of common).
Tag-along rights are fine. Pro-rata tag-along on founder transfers above small thresholds is normal.
Pro-rata rights mean investors get to participate in future rounds at their ownership percentage. This is normal. Watch for super pro-rata (more than their pro-rata share). That's a problem.
Information rights mean monthly or quarterly financials and a board package. Normal.
Most-favored-nation clauses mean the investor gets the benefit of any better terms granted to future investors. Annoying but not destructive at seed.
Founder transfer restrictions mean right of first refusal on founder share sales. Normal.
What to actually negotiate
You will not win every negotiation. Pick the battles that matter most:
Hold for 1x non-participating on liquidation preference. Walk if 2x+ or participating.
Hold for broad-based weighted average on anti-dilution. Walk if full ratchet.
Push for 2 founders + 1 investor or 1 founder + 1 investor + 1 independent (founder-selected) on board composition. Don't accept investor-majority at seed.
Push for post-money or split on ESOP pool location. This is often negotiable when other terms aren't.
Push the no-shop to 30-45 days.
Things you'll usually lose and can let go: most-favored-nation clauses, pro-rata rights, information rights, drag-along thresholds within normal ranges.
Timeline from term sheet to close
You receive the term sheet from the lead. Your lawyer reviews it and sends a red-line back within 1-2 days. The lead responds with partial concessions and pushback over the next 3-7 days. Two more rounds of red-lines happen over the following week. You sign around day 14-21.
Then you spend another 3-4 weeks on definitive documents (full equity purchase agreement, voting agreement, IRA, ROFR), diligence, and close.
A US round closes in 4-6 weeks from term sheet to wire. An Indian round usually takes 4-8 weeks. If it stretches past 8 weeks something is wrong. Investors are using the time to find reasons to walk.
Use a startup-focused law firm
Use a firm that does venture deals every week. Generalist law firms charge more, take longer, and miss the conventions of venture term sheets.
In India: SAM (Shardul Amarchand Mangaldas), Cyril Amarchand Mangaldas, or boutiques like Khaitan, Burgeon, IndusLaw. In the US: Cooley, Gunderson Dettmer, Wilson Sonsini, Orrick, Latham, or smaller specialists like the firms in Stripe Atlas's network.
Expect $15-40K in legal fees for a clean seed in the US, ₹3-8 lakh for India. Spending less here usually costs more downstream.
Before you sign
If you don't have a startup-focused lawyer engaged yet, pick one before you have a term sheet to react to. Read your existing convertible or SAFE notes (if any) and understand how they'll convert at the priced round. Most founders are surprised at the math. Build a simple model that lets you toggle different term sheet variations to see real dilution. If you're close to signing a term sheet, push back on any of the issues above before you sign.
We help founders read term sheets alongside their lawyer and tell them which battles to pick. Book a discovery call if you want a second set of eyes.



